Find out more about the technologies utilized in drug discovery and what the future holds for biotherapeutic drug metabolism studies in this Bioanalysis Zone interview with Kevin Ray (MilliporeSigma), as part of our 'In the Zone' feature on drug metabolism. You can find out more about drug metabolism on the website, at: https://www.bioanalysis-zone.com/2018/08/13/in-the-zone_inz_drug_metabolism/

The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada.